Monotherapy in patients with type 2 diabetes mellitus

On behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glucose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly.

Original languageEnglish
Pages (from-to)349-356
Number of pages8
JournalDiabetes and Metabolism Journal
Volume41
Issue number5
DOIs
Publication statusPublished - 2017 Oct 1

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Monotherapy in patients with type 2 diabetes mellitus'. Together they form a unique fingerprint.

  • Cite this

    On behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association (2017). Monotherapy in patients with type 2 diabetes mellitus. Diabetes and Metabolism Journal, 41(5), 349-356. https://doi.org/10.4093/dmj.2017.41.5.349